Full Press Release Details
argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022.
ARGX
argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022
Key Takeaway: argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022
Price reaction · baseline $375.44 (2022-10-18 close) · hit after-hours · clean, no other ARGX news in the window
day 0 close · peak
-3.9%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis